查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1904698

伴侶動物疼痛管理療法市場預測至2032年：按類型、形式、寵物類型、功能、分銷管道、最終用戶和地區分類的全球分析

Companion Animal Pain Management Therapies Market Forecasts to 2032 - Global Analysis By Type (Probiotics, Prebiotics, Postbiotics and Synbiotics), Form, Pet Type, Function, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的研究，預計到 2025 年，全球伴侶動物疼痛管理治療市場價值將達到 20.6 億美元，到 2032 年將達到 35 億美元，預測期內複合年成長率為 7.8%。

伴侶動物疼痛管理療法是指為支持和平衡伴侶動物的胃腸道菌叢而配製的膳食補充劑、功能性飼料和獸用營養產品。這些方案通常含有益生菌、益生元、後生元、消化酵素和合合益素，旨在改善營養吸收、增強免疫力、減少胃腸道疾病並促進寵物的整體健康。這些方案廣泛應用於犬、貓和其他伴侶動物，可解決腹瀉、食物過敏、壓力引起的腸道菌叢失衡以及與老齡化相關的消化功能衰退等問題。這些方案源自於營養學和獸醫學的傳統，體現了人們對預防保健和寵物長期健康的日益關注。

寵物擬人化且不斷上漲的醫療費用支出

寵物飼養已悄悄達到一個臨界點。人們不再只是飼養動物，而是珍愛它們。家庭將寵物視為家庭成員，並給予相應的投入。可支配收入的增加、城市生活的興起以及與寵物之間更深厚的情感紐帶，都推動了人們對預防性醫療保健的需求，而非被動治療。腸道健康解決方案與「滋養身體，預防疾病」這一古老的智慧完美契合。飼主主人越來越傾向於選擇經臨床驗證的益生菌產品來增強免疫力、改善消化功能並延長壽命，這支撐著市場的穩定成長。

高成本產品

儘管人們對益生菌的認知度不斷提高，但高昂的價格仍然是一大障礙。益生菌製劑依賴特殊菌株、先進的封裝技術、低溫運輸物流以及監管合規，所有這些都推高了成本。在價格敏感的市場，尤其是在新興經濟體，寵物飼主往往不願意長期補充益生菌。傳統的餵食方式和對基礎飲食的依賴進一步阻礙了益生菌的普及。在價格與日常消費水準更匹配之前，益生菌的市場滲透率可能仍將不均衡，尤其是在都市區和高所得市場。

產品創新與多元化

創新是這個市場真正煥發活力的關鍵所在。針對不同品種、年齡和健康狀況的定製配方正在開闢新的成長途徑。功能性零食、風味口香糖、滴劑和合益素配方，都提升了產品的易用性和吸引力。以科學為基礎，將腸道健康與免疫力、皮膚狀況和行為連結起來，增強了消費者的信任。那些在傳統與現代營養之間取得平衡，並不斷拓展產品形式與用途的品牌，將更有能力引領下一波成長浪潮，推動市場擴張。

監管和標籤方面的挑戰

監管是這個市場的隱形守門人。寵物益生菌介於飼料、營養補充劑和治療產品之間，處於灰色地帶，不同地區的監管規定差異顯著。菌株核准、允許的健康聲明、標籤語言和檢測要求等方面的差異，造成了合規的複雜性。對生產商而言，這意味著更高的成本和產品上市的延遲；對消費者而言，標籤不一致會削弱信任。如果沒有統一的標準，監管的不確定性將繼續對規模化生產和跨境擴張構成挑戰。

新冠疫情的感染疾病：

疫情改變了人們對寵物照護的關注。封鎖措施導致寵物飼養量激增，而人們健康意識的提高也促使飼主更加重視預防性營養。同時，供應鏈中斷影響了原料採購和分銷。電子商務蓬勃發展，成為營養補充品的主要銷售管道。儘管短期內物流挑戰確實存在，但長期影響是正面的。新冠疫情強化了人們的信念：對寵物而言，就像對人類一樣，健康始於內在。

預計在預測期內，膠囊產品細分市場將佔據最大的市場佔有率。

由於其精準性、穩定性和臨床可靠性，預計膠囊劑型在預測期內將佔據最大的市場佔有率。與粉末和液體相比，膠囊劑型能夠實現精準給藥，保護敏感的益生菌菌株，並具有更長的保存期限。獸醫經常推薦使用膠囊劑型來支持消化器官系統和免疫系統，這增強了消費者的信任。對於尋求可衡量、循證療效的寵物飼主，膠囊劑型值得信賴，並被視為傳統醫療實踐的延伸，以適應現代寵物預防保健的需求。

預計在預測期內，小型動物細分市場將呈現最高的複合年成長率。

預計在預測期內，小型哺乳動物市場將呈現最高的成長率，這主要得益於寵物數量的成長以及人們對它們脆弱消化器官系統的日益關注。兔子、天竺鼠和倉鼠等動物容易出現腸道菌叢失衡，因此益生菌已成為必需品而非可選項。城市生活、獸醫資源有限以及飼主知識的不斷提高，都在推動預防性營養補充品的普及。隨著人們對小眾營養領域的關注度不斷提高，針對小型哺乳動物的客製化腸道健康解決方案正成為一個蓬勃發展的市場。

佔比最大的地區：

由於寵物飼養量的增加、快速的都市化以及可支配收入的成長，預計亞太地區將在預測期內佔據最大的市場佔有率。中國、日本和韓國等國家正在經歷一場向高階寵物照護和預防性營養轉變的文化變革。長期以來對消化健康的重視與益生菌的普及自然契合。獸醫基礎設施的完善和先進寵物營養補充劑的日益普及進一步增強了該地區的需求，鞏固了亞太地區的主導地位。

年複合成長率最高的地區：

在預測期內，北美預計將實現最高的複合年成長率，這主要得益於消費者對寵物營養的高度認知、獸醫的強大影響力以及寵物營養的優質化。寵物飼主非常重視標籤檢視，並願意投資購買經過臨床檢驗的腸道健康產品。寵物保險的普及、先進的研發能力以及快速的產品創新正在推動寵物營養產品的市場成長。隨著預防保健深深植根於寵物飼養文化中，北美將繼續引領這個不斷發展的市場的創新和成長。

免費客製化服務：

購買此報告的客戶可以選擇以下免費自訂選項之一：

  • 公司概況
    • 對其他市場公司（最多 3 家公司）進行全面分析
    • 對主要企業進行SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶要求，提供主要國家的市場估算和預測以及複合年成長率（註：可行性需確認）。
  • 競爭標竿分析
    • 根據主要企業的產品系列、地理覆蓋範圍和策略聯盟進行基準分析

目錄

第1章執行摘要

第2章 前言

  • 摘要
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 促進要素
  • 抑制因素
  • 機會
  • 威脅
  • 終端用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球伴侶動物疼痛管理療法市場（按類型分類）

  • 益生菌
  • 益生元
  • 後生元
  • 合益素

6. 全球伴侶動物疼痛管理療法市場（按類型分類）

  • 藥片
  • 液體
  • 粉末
  • 膠囊
  • 點心

7. 全球伴侶動物疼痛管理治療市場（依寵物類型分類）

  • 狗
  • 貓
  • 小型哺乳動物
  • 其他寵物類型

8. 全球伴侶動物疼痛管理療法市場（依功能分類）

  • 消化/腸道健康
  • 皮膚和毛髮健康
  • 免疫調節
  • 口腔和牙齒健康
  • 新陳代謝/體重管理
  • 其他功能

9. 全球伴侶動物疼痛管理療法市場（依通路分類）

  • 獸醫診所/寵物醫院
  • 線上零售/電子商務
  • 寵物店
  • 超級市場和大賣場
  • 其他分銷管道

10. 全球伴侶動物疼痛管理療法市場（依最終用戶分類）

  • 寵物飼主
  • 動物收容所和飼養員
  • 獸醫專業人員

11. 全球伴侶動物疼痛管理療法市場（按地區分類）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 亞太其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第12章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第13章：企業概況

  • Nestle Purina PetCare
  • Vetoquinol SA
  • Mars Petcare
  • Virbac
  • Hill's Pet Nutrition
  • PetAg, Inc.
  • DSM-Firmenich
  • AnimalBiome
  • Chr. Hansen Holding A/S
  • Swedencare AB
  • Novozymes A/S
  • Kemin Industries
  • Archer Daniels Midland（ADM）
  • Vetnique Labs
  • Evonik Industries AG
Product Code: SMRC32976

According to Stratistics MRC, the Global Companion Animal Pain Management Therapies Market is accounted for $2.06 billion in 2025 and is expected to reach $3.50 billion by 2032 growing at a CAGR of 7.8% during the forecast period. Companion Animal Pain Management Therapies refer to dietary supplements, functional feeds, and veterinary nutrition products formulated to support and balance the digestive microbiome of companion animals. These solutions typically include probiotics, prebiotics, postbiotics, digestive enzymes, and synbiotics designed to improve nutrient absorption, strengthen immunity, reduce gastrointestinal disorders, and enhance overall pet well-being. Used across dogs, cats, and other companion animals, they address issues such as diarrhea, food sensitivities, stress-related gut imbalance, and aging-related digestive decline. Rooted in nutritional science and veterinary tradition, these solutions reflect a growing emphasis on preventive care and long-term pet health.

Market Dynamics:

Driver:

Rising Pet Humanization & Healthcare Spending

Pet ownership has quietly crossed a threshold: animals are no longer kept, they are cared for. Across households, pets are treated as family, and families invest accordingly. Rising disposable incomes, urban lifestyles, and deeper emotional bonds are driving demand for preventive healthcare rather than reactive treatment. Gut health solutions fit this old wisdom perfectly nourish the body to avoid disease. Owners increasingly seek clinically backed probiotics to improve immunity, digestion, and longevity, sustaining steady market momentum.

Restraint:

High Product Costs

Despite growing awareness, premium pricing remains a stubborn barrier. Probiotic formulations rely on specialized strains, advanced encapsulation, cold-chain logistics, and regulatory compliance, all of which elevate costs. In price-sensitive markets, especially emerging economies, pet owners often hesitate to commit to long-term supplementation. Traditional feeding habits and reliance on basic diets further slow adoption. Until costs align more closely with everyday spending patterns, market penetration will remain uneven, particularly beyond urban and high-income segments.

Opportunity:

Product Innovation & Diversification

Innovation is where this market truly breathes. Customized formulations by species, age, breed, and health condition are opening new growth paths. Functional treats, flavored chews, liquid drops, and synbiotic blends are making compliance easier and more appealing. Science driven storytelling linking microbiome health to immunity, skin, and behavior strengthens consumer trust. Brands that balance tradition with modern nutritional science, while expanding formats and applications, are well positioned to lead the next growth wave. Thus, it drives the market expansion.

Threat:

Regulatory & Labeling Challenges

Regulation is the quiet gatekeeper of this market. Pet probiotics sit in a gray zone between feed, supplement, and therapeutic product, and rules differ sharply by region. Variations in strain approval, permissible health claims, labeling language, and testing requirements create compliance complexity. For manufacturers, this raises costs and slows product launches. For consumers, inconsistent labeling can erode trust. Unless harmonized standards emerge, regulatory uncertainty will continue to challenge scalability and cross-border expansion.

Covid-19 Impact:

The pandemic reshaped pet care priorities. Lockdowns fueled a surge in pet adoption, while heightened health awareness pushed owners toward preventive nutrition. At the same time, supply chain disruptions affected ingredient sourcing and distribution. E-commerce emerged stronger, becoming a primary sales channel for supplements. While short-term logistics challenges were real, the long-term effect was positive COVID-19 reinforced the belief that health begins within, for pets as much as for people.

The capsules segment is expected to be the largest during the forecast period

The capsules segment is expected to account for the largest market share during the forecast period, due to its precision, stability, and clinical credibility. Capsules allow accurate dosing, protect sensitive probiotic strains, and offer longer shelf life compared to powders or liquids. Veterinarians frequently recommend capsule formats for targeted digestive and immune support, reinforcing consumer confidence. For pet owners seeking measurable, science-backed outcomes, capsules feel dependable and serious an extension of traditional medical practice adapted for modern preventive pet care.

The small mammals segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the small mammals segment is predicted to witness the highest growth rate, due to rising adoption and growing awareness of their fragile digestive systems. Animals such as rabbits, guinea pigs, and hamsters are highly prone to gut imbalance, making probiotics essential rather than optional. Urban living, limited veterinary access, and increased owner education are driving preventive supplementation. As niche nutrition gains attention, tailored gut health solutions for small mammals are emerging as a fast-growing opportunity.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share, due to expanding pet ownership, rapid urbanization, and rising disposable incomes. Countries such as China, Japan, and South Korea are seeing a cultural shift toward premium pet care and preventive nutrition. Long-standing traditions that value digestive health align naturally with probiotic adoption. Improved veterinary infrastructure and growing availability of advanced pet supplements further strengthen regional demand, securing Asia Pacific's leading position.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to high awareness, strong veterinary influence, and premiumization of pet nutrition. Pet owners are highly label-conscious and willing to invest in clinically validated gut health products. Widespread pet insurance, advanced R&D capabilities and rapid product innovation accelerate adoption. With preventive care deeply embedded in pet ownership culture, North America continues to set the pace for innovation and growth in this evolving market.

Key players in the market

Some of the key players in Companion Animal Pain Management Therapies Market include Nestle Purina PetCare, Vetoquinol SA, Mars Petcare, Virbac, Hill's Pet Nutrition, PetAg, Inc., DSM-Firmenich, AnimalBiome, Chr. Hansen Holding A/S, Swedencare AB, Novozymes A/S, Kemin Industries, Archer Daniels Midland (ADM), Vetnique Labs and Evonik Industries AG.

Key Developments:

In October 2025, Mars Petcare and Big Idea Ventures have hand-picked three innovative startups for their 2025 Next Generation Pet Food Program, spotlighting sustainable biotech ingredients and circular feed solutions to transform pet nutrition and reduce environmental impact.

In March 2025, Mars, Incorporated has extended its partnership with the Washington Spirit, becoming the team's Official Petcare Partner, with its logo featured on jerseys and signage, community ticket donations, pet-friendly game nights, and collaborative fan and pet experiences.

Types Covered:

  • Probiotics
  • Prebiotics
  • Postbiotics
  • Synbiotics

Forms Covered:

  • Pills
  • Liquids
  • Powders
  • Capsules
  • Treats & Snacks

Pet Types Covered:

  • Dogs
  • Cats
  • Small Mammals
  • Other Pet Types

Functions Covered:

  • Digestive / Gut Health
  • Skin & Coat Health
  • Immune Modulation
  • Oral & Dental Health
  • Metabolic & Weight Management
  • Other Functions

Distribution Channels Covered:

  • Veterinary Clinics / Pet Hospitals
  • Online Retail / E-commerce
  • Pet Shops
  • Supermarkets & Hypermarkets
  • Other Distribution Channels

End Users Covered:

  • Pet Owners
  • Animal Shelters & Breeders
  • Veterinary Professionals

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Companion Animal Pain Management Therapies Market, By Type

  • 5.1 Introduction
  • 5.2 Probiotics
  • 5.3 Prebiotics
  • 5.4 Postbiotics
  • 5.5 Synbiotics

6 Global Companion Animal Pain Management Therapies Market, By Form

  • 6.1 Introduction
  • 6.2 Pills
  • 6.3 Liquids
  • 6.4 Powders
  • 6.5 Capsules
  • 6.6 Treats & Snacks

7 Global Companion Animal Pain Management Therapies Market, By Pet Type

  • 7.1 Introduction
  • 7.2 Dogs
  • 7.3 Cats
  • 7.4 Small Mammals
  • 7.5 Other Pet Types

8 Global Companion Animal Pain Management Therapies Market, By Function

  • 8.1 Introduction
  • 8.2 Digestive / Gut Health
  • 8.3 Skin & Coat Health
  • 8.4 Immune Modulation
  • 8.5 Oral & Dental Health
  • 8.6 Metabolic & Weight Management
  • 8.7 Other Functions

9 Global Companion Animal Pain Management Therapies Market, By Distribution Channel

  • 9.1 Introduction
  • 9.2 Veterinary Clinics / Pet Hospitals
  • 9.3 Online Retail / E-commerce
  • 9.4 Pet Shops
  • 9.5 Supermarkets & Hypermarkets
  • 9.6 Other Distribution Channels

10 Global Companion Animal Pain Management Therapies Market, By End User

  • 10.1 Introduction
  • 10.2 Pet Owners
  • 10.3 Animal Shelters & Breeders
  • 10.4 Veterinary Professionals

11 Global Companion Animal Pain Management Therapies Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Nestle Purina PetCare
  • 13.2 Vetoquinol SA
  • 13.3 Mars Petcare
  • 13.4 Virbac
  • 13.5 Hill's Pet Nutrition
  • 13.6 PetAg, Inc.
  • 13.7 DSM-Firmenich
  • 13.8 AnimalBiome
  • 13.9 Chr. Hansen Holding A/S
  • 13.10 Swedencare AB
  • 13.11 Novozymes A/S
  • 13.12 Kemin Industries
  • 13.13 Archer Daniels Midland (ADM)
  • 13.14 Vetnique Labs
  • 13.15 Evonik Industries AG

List of Tables

  • Table 1 Global Companion Animal Pain Management Therapies Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Companion Animal Pain Management Therapies Market Outlook, By Type (2024-2032) ($MN)
  • Table 3 Global Companion Animal Pain Management Therapies Market Outlook, By Probiotics (2024-2032) ($MN)
  • Table 4 Global Companion Animal Pain Management Therapies Market Outlook, By Prebiotics (2024-2032) ($MN)
  • Table 5 Global Companion Animal Pain Management Therapies Market Outlook, By Postbiotics (2024-2032) ($MN)
  • Table 6 Global Companion Animal Pain Management Therapies Market Outlook, By Synbiotics (2024-2032) ($MN)
  • Table 7 Global Companion Animal Pain Management Therapies Market Outlook, By Form (2024-2032) ($MN)
  • Table 8 Global Companion Animal Pain Management Therapies Market Outlook, By Pills (2024-2032) ($MN)
  • Table 9 Global Companion Animal Pain Management Therapies Market Outlook, By Liquids (2024-2032) ($MN)
  • Table 10 Global Companion Animal Pain Management Therapies Market Outlook, By Powders (2024-2032) ($MN)
  • Table 11 Global Companion Animal Pain Management Therapies Market Outlook, By Capsules (2024-2032) ($MN)
  • Table 12 Global Companion Animal Pain Management Therapies Market Outlook, By Treats & Snacks (2024-2032) ($MN)
  • Table 13 Global Companion Animal Pain Management Therapies Market Outlook, By Pet Type (2024-2032) ($MN)
  • Table 14 Global Companion Animal Pain Management Therapies Market Outlook, By Dogs (2024-2032) ($MN)
  • Table 15 Global Companion Animal Pain Management Therapies Market Outlook, By Cats (2024-2032) ($MN)
  • Table 16 Global Companion Animal Pain Management Therapies Market Outlook, By Small Mammals (2024-2032) ($MN)
  • Table 17 Global Companion Animal Pain Management Therapies Market Outlook, By Other Pet Types (2024-2032) ($MN)
  • Table 18 Global Companion Animal Pain Management Therapies Market Outlook, By Function (2024-2032) ($MN)
  • Table 19 Global Companion Animal Pain Management Therapies Market Outlook, By Digestive / Gut Health (2024-2032) ($MN)
  • Table 20 Global Companion Animal Pain Management Therapies Market Outlook, By Skin & Coat Health (2024-2032) ($MN)
  • Table 21 Global Companion Animal Pain Management Therapies Market Outlook, By Immune Modulation (2024-2032) ($MN)
  • Table 22 Global Companion Animal Pain Management Therapies Market Outlook, By Oral & Dental Health (2024-2032) ($MN)
  • Table 23 Global Companion Animal Pain Management Therapies Market Outlook, By Metabolic & Weight Management (2024-2032) ($MN)
  • Table 24 Global Companion Animal Pain Management Therapies Market Outlook, By Other Functions (2024-2032) ($MN)
  • Table 25 Global Companion Animal Pain Management Therapies Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 26 Global Companion Animal Pain Management Therapies Market Outlook, By Veterinary Clinics / Pet Hospitals (2024-2032) ($MN)
  • Table 27 Global Companion Animal Pain Management Therapies Market Outlook, By Online Retail / E-commerce (2024-2032) ($MN)
  • Table 28 Global Companion Animal Pain Management Therapies Market Outlook, By Pet Shops (2024-2032) ($MN)
  • Table 29 Global Companion Animal Pain Management Therapies Market Outlook, By Supermarkets & Hypermarkets (2024-2032) ($MN)
  • Table 30 Global Companion Animal Pain Management Therapies Market Outlook, By Other Distribution Channels (2024-2032) ($MN)
  • Table 31 Global Companion Animal Pain Management Therapies Market Outlook, By End User (2024-2032) ($MN)
  • Table 32 Global Companion Animal Pain Management Therapies Market Outlook, By Pet Owners (2024-2032) ($MN)
  • Table 33 Global Companion Animal Pain Management Therapies Market Outlook, By Animal Shelters & Breeders (2024-2032) ($MN)
  • Table 34 Global Companion Animal Pain Management Therapies Market Outlook, By Veterinary Professionals (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.